108 Quick summary: A new study reveals a steep rise in invasive breast cancer among Asian American women over the past two decades, with incidence rates increasing by more than 3% annually and rising faster than in any other US ethnic group. The trend is particularly pronounced among women under 50 and those diagnosed with aggressive, advanced stage subtypes, effectively closing the historical health gap between younger Asian American and non-Hispanic White women. For public policy and healthcare practice, these concerning findings emphasize the critical need to disaggregate demographic data and implement culturally appropriate screening guidelines to safeguard the physical well-being and long-term health equity of diverse communities. A new study led by researchers at UC San Francisco has found a steep rise in invasive breast cancer among Asian American women over the past two decades, with rates increasing faster than in any other US ethnic group. The trend is most pronounced among women under 50 and those diagnosed with advanced-stage or aggressive subtypes of the disease. Published in JAMA Network Open, the study found that breast cancer incidence rose more than 3% per year in nearly every Asian American ethnic group, with even sharper increases among Chinese and Vietnamese women. By comparison, breast cancer rates among Native Hawaiian women, already among the highest for US women, rose by only about 1% annually. Researchers said the overall rise is unlikely to stem from increased screening, since screening tends to catch cancers earlier rather than at advanced stages. Instead, cancers that had already spread by diagnosis accounted for much of the increase. Triple-negative breast cancer, considered the most aggressive subtype, rose more than 6% annually among Chinese American women between 2017 and 2022. “These patterns are highly concerning from a disparities standpoint,” said senior author Scarlett Lin Gomez, PhD, professor of epidemiology and biostatistics at UCSF. “They underscore why it is so important to move beyond treating Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPI) as a single population.” The research team analysed roughly 150,000 cases of invasive breast cancer diagnosed between 2000 and 2022, drawing on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Programme. The analysis covered nine detailed populations across 14 states, representing about two-thirds of the total US AANHPI population. Historically, Asian American women other than Native Hawaiians have had lower breast cancer rates than non-Hispanic White women. That gap is now closing quickly: by 2022, incidence among Asian American women under 50 had become comparable to that of White women in the same age group. Why breast cancer is rising so quickly among women under 50 remains unclear. Changing reproductive patterns, diet, and other lifestyle factors may contribute, but researchers said these do not fully account for the trend. Some of the increase in specific communities may stem from risk factors not yet identified. Two UCSF-based projects, the CRANE breast cancer study and the ASPIRE cohort study, are expected to shed light on these open questions. “Understanding why breast cancer is increasing so rapidly in these communities is critical,” Gomez said. “At the same time, we need to ensure that women across all AANHPI communities have access to culturally appropriate education, screening, and timely follow-up care.” Health experts have long documented variation in cancer outcomes across US ethnic groups. AANHPI populations are frequently grouped together in national statistics, a practice that can obscure meaningful differences between communities such as Chinese, Vietnamese, Korean, Japanese, and South Asian populations. By examining 14 states with large AANHPI populations individually, the researchers were able to detect patterns that aggregated national data might have missed, offering a possible model for future epidemiological research on diverse populations. Factors such as immigration patterns, acculturation, environmental exposures, and genetics remain areas of ongoing investigation. Public health researchers are increasingly emphasising awareness among younger women, whose risks may not be fully addressed by traditional screening guidelines. While early detection is still considered vital, the study’s findings suggest that advanced-stage disease, not delayed diagnosis alone, is driving much of the increase, pointing to gaps in prevention as well as treatment access. Within AANHPI communities, access to care can vary widely due to language barriers, cultural attitudes towards screening, and socioeconomic factors. The American Cancer Society and cancer centres nationwide are expected to review the findings as they revisit screening recommendations and outreach efforts. Researchers anticipate growing calls for more inclusive clinical trials and community-based research. As the Asian American population continues to grow and diversify, addressing these emerging disparities is seen as key to reducing the overall cancer burden and advancing health equity.